Business
CCI may hold senior execs of steel companies accountable – The Times of India
CCI has invoked section 48 of the law, which extends liability to senior executives in charge of company operations. Under this provision, individuals can be held personally accountable and face penalties of up to 10% of their average income over the last three financial years if the violations are proven.Last week, TOI had sent questionnaires to several companies that are under probe but they did not respond to the queries.Based on the investigation by its director general (DG) investigation, the CCI issued an order to the 31 steel companies named in the probe. The firms were directed to submit their audited financial statements, including balance sheets, income and expenditure accounts and profit & loss accounts, for the period from 2015-16 to 2022-23. They have also been asked to provide certified details of turnover linked to the alleged violations, this information is usually used to assess potential penalties, if any.
Business
FM Sitharaman rules out roadmap for PSU bank mergers, panel to review sector reforms – The Times of India
The government currently has no roadmap for mergers among public sector banks, Finance Minister Nirmala Sitharaman said, indicating that consolidation is not under active consideration even as a new banking reform panel is set to review the sector’s future.“I am not familiar with any roadmap…there isn’t one,” Sitharaman said in a media briefing after her post-Budget customary address to the Board of the Reserve Bank of India, PTI reported.She clarified that bank consolidation was neither discussed during Budget preparations nor raised in recent deliberations, though the proposed High-Level Committee on Banking for Viksit Bharat will examine all aspects related to strengthening the banking ecosystem.“Bank consolidation was not a subject here, nor was it a subject before the Budget, but the Committee, which is now being appointed, once the terms of reference are given, they will look into every aspect of how to strengthen Indian banking,” she said.In the Union Budget 2026-27, Sitharaman proposed setting up a ‘High Level Committee on Banking for Viksit Bharat’ to comprehensively review India’s banking sector and align it with the country’s growth goals while safeguarding financial stability, inclusion and consumer protection.“I propose setting up a ‘High Level Committee on Banking for Viksit Bharat’ to comprehensively review the sector and align it with India’s next phase of growth, while safeguarding financial stability, inclusion and consumer protection,” she had said in the Budget speech on February 1.The committee is expected to draw up a blueprint aimed at creating mega lenders capable of meeting the financing needs of a developed India.As part of broader financial sector reforms, the Budget also proposed restructuring Power Finance Corporation (PFC) and Rural Electrification Corporation (REC) to achieve scale and improve efficiency in public sector NBFCs. REC is a subsidiary of state-owned power sector lender PFC, and both institutions play a key role in financing power generation, transmission and distribution projects.In March 2019, PFC completed the acquisition of a majority stake in REC Ltd by transferring Rs 14,500 crore to the government. PFC acquired 103.94 crore shares, representing a 52.63 per cent stake, along with management control, at Rs 139.50 per share following approval from the Cabinet Committee on Economic Affairs.Commenting on the banking sector’s health, RBI Governor Sanjay Malhotra said banks are adequately capitalised and capable of sustaining credit growth for the next four to five years, supporting the economy’s financing needs.He added that deposit growth is now keeping pace with credit expansion.On moderation in net foreign direct investment (FDI), Malhotra said gross FDI inflows have continued to rise.Last year, he said, “It increased by about 14-15 per cent. Even this year, gross FDI has increased, and the growth rate is also high. It’s because of repatriations of those people who had done earlier FDI. It has gone out. The net (FDI) has decreased”.Similarly, he said Indian companies are increasingly investing overseas as domestic economic measures have strengthened confidence, which has also contributed to lower net FDI levels.
Business
Trump vows higher tariffs on countries that ‘play games’ with existing trade deals
On the day that Trump announced the IEEPA tariffs last April, the tariffs on his products went from zero to 30%, Smeaton told BBC Radio 4’s Today programme. Afterwards, they went up to 100%, then 145%, and eventually a rate of 30% was paid. This later changed to 20% and, for a few hours on Friday after the ruling, it was zero again, then up to 10%, and on Saturday, 15%.
Business
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024.
Shelby Knowles | Bloomberg | Getty Images
Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month’s worth of doses in a single pen.
Cash-paying patients can get the multi-dose device, called KwikPen, on the company’s direct-to-consumer website, LillyDirect. Prices start at $299 per month for the lowest dose level.
The pen could serve as a more convenient option for some patients, as it reduces the number of devices they have to use in a month to take the drug. Patients can use one pen to take four weekly doses of Zepbound.
Currently, patients on the treatment use a different single-dose autoinjector device each week. Lilly also offers single-dose vials of Zepbound, which requires users to draw the medication into a syringe and inject themselves.
The announcement comes as Lilly works to sustain the early success of Zepbound, which has exploded in demand since it first entered the market in late 2023. LillyDirect has been key to Zepbound’s growth, and rolling out a new form of the drug on the platform could attract even more patients.
The torrid growth of Zepbound has helped Eli Lilly seize a majority share of the weight-loss drug market from rival Novo Nordisk. In the company’s fourth quarter, Zepbound brought in $4.2 billion in U.S. revenue, a 122% spike from the previous year.
In a release, Lilly said the Food and Drug Administration approved a label expansion for Zepbound to include the multi-dose device.
The KwikPen is already used for other drugs, such as Lilly’s popular diabetes medication, Mounjaro.
“As part of our commitment to supporting people living with obesity in their weight management journey, we are introducing a new option with the Zepbound KwikPen, a device trusted by patients globally and in the United States for other Lilly medicines,” said Ilya Yuffa, the president of Lilly USA and Global Customer Capabilities, in the release.
-
Entertainment6 days agoQueen Camilla reveals her sister’s connection to Princess Diana
-
Tech6 days agoRakuten Mobile proposal selected for Jaxa space strategy | Computer Weekly
-
Politics6 days agoRamadan moon sighted in Saudi Arabia, other Gulf countries
-
Entertainment6 days agoRobert Duvall, known for his roles in "The Godfather" and "Apocalypse Now," dies at 95
-
Politics6 days agoTarique Rahman Takes Oath as Bangladesh’s Prime Minister Following Decisive BNP Triumph
-
Business6 days agoTax Saving FD: This Simple Investment Can Help You Earn And Save More
-
Tech6 days agoBusinesses may be caught by government proposals to restrict VPN use | Computer Weekly
-
Sports6 days agoUsman Tariq backs Babar and Shaheen ahead of do-or-die Namibia clash
